Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
Statement |
---|
So I think we’re in pretty good shape, actually, Marla |
The clinical team in Aethlon continues to make strides toward initiating oncology studies in India and Australia |
As a result of the changes in expenses that I just noted, the company’s net loss increased to $3.6 million for the 3 months ended December 31, 2023, from $2.8 million in the 3 months ended December 31, 2022 |
Great |
We are poised – I have been really pushing hard on this, Anthony, since I was named interim CEO |
James Frakes Well, I did push to make the oncology effort as the highest priority, but there was momentum with the organ transplant work |
Thanks for your update |
James Frakes Thanks, Steve, and good afternoon again, everyone |
It’s pretty interesting stuff |
Marla Marin Thank you |
Both our payroll expense and our overall operating expenses would have actually decreased from the 2022 period |
Thank you very much |
Thanks |
Thanks |
Hello |
Michael Miller Thank you, operator and good afternoon everyone |
We have generated additional data |
You may now disconnect your lines and have a wonderful day. |
Statement |
---|
While our R&D team has started to quantify our internal data, the results to date are inconclusive |
So it would need to be a massive outbreak with a lot of people in the ICUs to cause a problem |
But again, the issue has been with the evolving COVID epidemic, there have been patients who are affected who aren’t critically ill |
They couldn’t even count the extracellular PD-L1 on the extracellular vesicles two months ago, and now they can count the total aggregates, but they have – it’s just inconclusive |
Please consider a small donation if you think this website provides you with relevant information